Radium bromide Institute had four grams of radium total, which at the time was more than half the world supply. Countries all over the world set out to make as much radium as possible, a time consuming and expensive task. It was reported in "Science" magazine in 1919 that the United States had produced approximately 55 grams of radium since 1913, which was also more than half the radium produced in the world at the time. A principal source for radium is pitchblende, which holds a total of 257 mg of radium per ton of UO. Obviously with so little product recovered
Radium chloride radon gas which in turn was used as a cancer treatment. Radium-223 dichloride (USP, radium chloride Ra 223), tradename Xofigo (formerly Alpharadin), is an alpha-emitting radiopharmaceutical. Bayer received FDA approval for this drug to treat prostate cancer osteoblastic bone metastases in May 2013. Radium chloride Ra 223 is one of the most potent drugs known. One dose (50 kBq/kg) in an adult is about 60 nanograms; this amount is 1/1000 the weight of an eyelash (75 micrograms). Radium chloride Radium chloride (RaCl) is a chemical compound of radium and chlorine, and the first radium compound isolated in a pure state.